Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of GMRx2 (a Single Pill Combination Containing Telmisartan/Amlodipine/Indapamide) Compared to Placebo for the Treatment of Hypertension

NCT04518306 is registered in ClinicalTrials.gov with George Medicines PTY Limited as lead sponsor.

NCT NCT04518306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04518306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of GMRx2 (a Single Pill Combination Containing Telmisartan/Amlodipine/Indapamide) Compared to Placebo for the Treatment of Hypertension
Lead sponsor
George Medicines PTY Limited
Phase
Phase 3
Overall status
Completed
Start date
June 14, 2021
Completion date
October 18, 2023
Enrollment
755 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension